Lars Lind Selected Research

Brain Natriuretic Peptide (Natrecor)

12/2021	Large-Scale Plasma Protein Profiling of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure.
10/2018	Circulating endostatin and the incidence of heart failure.
1/2018	Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.
10/2016	Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.
12/2015	Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip.
2/2015	Relation between cardiovascular disease risk markers and brain infarcts detected by magnetic resonance imaging in an elderly population.
10/2013	Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.
7/2013	Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals.
5/2011	Unrecognized myocardial scars detected by delayed-enhanced MRI are associated with increased levels of NT-proBNP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Lind Research Topics

Disease

79	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2002
52	Insulin Resistance 01/2023 - 07/2002
45	Obesity 11/2023 - 10/2002
37	Inflammation (Inflammations) 01/2023 - 08/2003
37	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2008
33	Hypertension (High Blood Pressure) 11/2023 - 01/2000
31	Myocardial Infarction 11/2023 - 03/2003
30	Atherosclerosis 01/2023 - 12/2002
23	Heart Failure 01/2024 - 07/2007
20	Stroke (Strokes) 01/2024 - 03/2002
17	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2012 - 04/2002
16	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 01/2006
15	Coronary Disease (Coronary Heart Disease) 01/2024 - 08/2003
12	Chronic Renal Insufficiency 01/2023 - 10/2009
12	Essential Hypertension 08/2009 - 01/2002
11	Ischemic Stroke 01/2024 - 12/2015
11	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 01/2009
11	Neoplasms (Cancer) 01/2022 - 08/2011
9	Overweight 11/2021 - 01/2010
7	Diabetes Mellitus 04/2024 - 07/2012
6	Carotid Artery Diseases 11/2023 - 04/2009
6	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2018
6	Atrial Fibrillation 01/2023 - 12/2006
6	Body Weight (Weight, Body) 01/2019 - 07/2004
5	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2002
5	Atherosclerotic Plaque (Atheroma) 01/2020 - 09/2011
5	Hypertrophy 04/2013 - 03/2003
4	Hyperinsulinism (Hyperinsulinemia) 03/2021 - 04/2003
4	Necrosis 01/2021 - 03/2009
4	Weight Loss (Weight Reduction) 01/2020 - 07/2003
4	Cicatrix (Scar) 02/2017 - 07/2009
4	Albuminuria 01/2017 - 01/2013
3	COVID-19 01/2022 - 01/2021
3	Heart Diseases (Heart Disease) 12/2021 - 10/2013
3	Hyperglycemia 03/2021 - 05/2010
3	Infarction (Infarctions) 01/2021 - 02/2015

Drug/Important Bio-Agent (IBA)

47	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2009
38	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2003
37	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 08/2002
33	Insulin (Novolin)FDA Link 01/2023 - 07/2002
32	LipidsIBA 01/2023 - 08/2002
30	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 01/2000
28	CholesterolIBA 11/2023 - 03/2003
17	HDL CholesterolIBA 10/2023 - 10/2002
17	Triglycerides (Triacylglycerol)IBA 12/2022 - 02/2008
17	LDL CholesterolIBA 12/2021 - 02/2006
14	AlbuminsIBA 12/2021 - 07/2002
14	C-Reactive ProteinIBA 11/2018 - 01/2007
13	Persistent Organic PollutantsIBA 09/2020 - 08/2011
12	CalciumIBA 01/2024 - 06/2009
12	ProinsulinIBA 01/2023 - 03/2003
11	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2009
11	CreatinineIBA 12/2021 - 01/2013
11	Atenolol (Tenormin)FDA LinkGeneric 08/2009 - 04/2002
11	Irbesartan FDA LinkGeneric 08/2009 - 04/2002
10	Blood Proteins (Serum Proteins)IBA 11/2023 - 01/2017
10	Troponin IIBA 01/2022 - 09/2008
10	Growth Differentiation Factor 15IBA 02/2020 - 10/2009
9	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2021 - 05/2011
9	Polychlorinated Biphenyls (PCBs)IBA 09/2020 - 08/2011
9	Blood Glucose (Blood Sugar)IBA 03/2017 - 07/2002
8	Fatty Acids (Saturated Fatty Acids)IBA 12/2022 - 07/2002
8	Vitamin D FDA LinkGeneric 12/2018 - 06/2009
8	Parathyroid Hormone (Parathormone)IBA 02/2015 - 06/2009
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020 - 01/2012
7	AdiponectinIBA 09/2019 - 03/2009
6	Lipoproteins (Lipoprotein)IBA 01/2024 - 12/2001
6	omega-Chloroacetophenone (Mace)IBA 01/2021 - 05/2013
6	LeptinIBA 12/2020 - 12/2003
6	HDL LipoproteinsIBA 02/2020 - 03/2004
6	Cystatin CIBA 10/2016 - 01/2013
6	ApolipoproteinsIBA 02/2014 - 03/2002
6	MineralsIBA 05/2013 - 06/2009
5	Hormones (Hormone)IBA 01/2022 - 01/2012
5	oxidized low density lipoproteinIBA 02/2020 - 12/2002
5	EndostatinsIBA 10/2018 - 11/2013
5	EnzymesIBA 10/2016 - 03/2009
5	Angiotensin IIIBA 03/2004 - 05/2002
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2023 - 12/2015
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 01/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 04/2013
4	Cholesterol Esters (Cholesteryl Esters)IBA 12/2017 - 07/2002
4	Apolipoproteins B (ApoB)IBA 01/2017 - 02/2006
4	bisphenol AIBA 01/2017 - 09/2011
4	Dichlorodiphenyl Dichloroethylene (DDE)IBA 03/2016 - 04/2012
4	Indicators and Reagents (Reagents)IBA 10/2013 - 03/2012
4	Fibroblast Growth Factor-23IBA 05/2013 - 10/2009
4	Dietary Fats (Dietary Fat)IBA 12/2006 - 07/2002
3	Immunoglobulin M (IgM)IBA 01/2024 - 01/2018
3	Plasminogen Activators (Plasminogen Activator)IBA 11/2023 - 12/2015
3	FluorocarbonsIBA 11/2023 - 01/2023
3	C-PeptideIBA 01/2023 - 05/2004
3	Phospholipids (Phosphatides)FDA LinkGeneric 12/2022 - 10/2016
3	Carboxylic AcidsIBA 11/2021 - 01/2018
3	Protons (Proton)IBA 01/2021 - 04/2020
3	LigandsIBA 01/2021 - 11/2017
3	Complement System Proteins (Complement)IBA 01/2020 - 06/2014
3	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2019 - 10/2007
3	Linoleic Acid (Linoleate)IBA 01/2019 - 12/2006

Therapy/Procedure

6	Therapeutics 11/2023 - 04/2002